BREMER, F. P., CZECZKO, N. G., COLLAÇO, L. M., RUTZ, L. E. A. C., GIONEDIS, G., & YAMAKAWA, C. K. (2020). ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN PATIENTS WITH COLORECTAL CANCER? Arq Bras Cir Dig.
Citação norma ChicagoBREMER, Fabiola Pabst, Nicolau Gregori CZECZKO, Luiz Martins COLLAÇO, Letícia Elizabeth Augustin Czeczko RUTZ, Guilherme GIONEDIS, and Camila Kienen YAMAKAWA. "ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN PATIENTS WITH COLORECTAL CANCER?" Arq Bras Cir Dig 2020.
Citação norma MLABREMER, Fabiola Pabst, et al. "ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN PATIENTS WITH COLORECTAL CANCER?" Arq Bras Cir Dig 2020.